George Thomas, Equity Fund Manager at Quantum AMC, expects IT spending to improve, benefiting large-cap IT names. He also forecasts larger private banks to perform better due to better underwriting and improved liquidity. Thomas notes that while most sectors are fully valued, financials offer some room for growth. Expectations of market support from domestic funds remain positive.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,